Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coffin

Showing results (431-440 of 477) with videos related to

Pageof 48
Sort By:
Human Pathology|April 24, 2012
Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinasesJustin M M Cates, Jennifer O Black, Doha M Itani, et al.
Life Science Alliance|July 14, 2025
In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individualsAdam A Capoferri, Rachel Sklutuis, Toluleke O Famuyiwa, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 25, 2012
Nuclear p63 expression in osteoblastic tumorsMichael E Kallen, Melinda E Sanders, Adriana L Gonzalez, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
<i>In vivo</i> detection of HIV-1 antisense transcripts in untreated and ART-treated individualsAdam A Capoferri, Rachel Sklutuis, Toluleke O Famuyiwa, et al.
American Journal of Clinical Pathology|July 2, 2002
Pediatric laboratory medicine: current challenges and future opportunitiesCheryl M Coffin, Marilyn S Hamilton, Theodore J Pysher, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infectionNancie M Archin, Naveen K Vaidya, Joann D Kuruc, et al.
The Journal of Infectious Diseases|February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomesTimothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
Viruses|January 30, 2020
Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV InfectionsElizabeth M Anderson, Francesco R Simonetti, Robert J Gorelick, et al.
Elife|November 17, 2025
The role of co-infection in the pathogenesis of acute SARS-CoV-2 infection and development of post-acute sequelae: A perspectiveTimothy J Henrich, Christopher P Montgomery, Joerg Graf, et al.
JCI Insight|September 6, 2019
Linked dual-class HIV resistance mutations are associated with treatment failureValerie F Boltz, Wei Shao, Michael J Bale, et al.
Pageof 48

Showing results (431-440 of 477) with videos related to

Sort By:
Pageof 48
Human Pathology|April 24, 2012
Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinasesJustin M M Cates, Jennifer O Black, Doha M Itani, et al.
Life Science Alliance|July 14, 2025
In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individualsAdam A Capoferri, Rachel Sklutuis, Toluleke O Famuyiwa, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 25, 2012
Nuclear p63 expression in osteoblastic tumorsMichael E Kallen, Melinda E Sanders, Adriana L Gonzalez, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
<i>In vivo</i> detection of HIV-1 antisense transcripts in untreated and ART-treated individualsAdam A Capoferri, Rachel Sklutuis, Toluleke O Famuyiwa, et al.
American Journal of Clinical Pathology|July 2, 2002
Pediatric laboratory medicine: current challenges and future opportunitiesCheryl M Coffin, Marilyn S Hamilton, Theodore J Pysher, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infectionNancie M Archin, Naveen K Vaidya, Joann D Kuruc, et al.
The Journal of Infectious Diseases|February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomesTimothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
Viruses|January 30, 2020
Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV InfectionsElizabeth M Anderson, Francesco R Simonetti, Robert J Gorelick, et al.
Elife|November 17, 2025
The role of co-infection in the pathogenesis of acute SARS-CoV-2 infection and development of post-acute sequelae: A perspectiveTimothy J Henrich, Christopher P Montgomery, Joerg Graf, et al.
JCI Insight|September 6, 2019
Linked dual-class HIV resistance mutations are associated with treatment failureValerie F Boltz, Wei Shao, Michael J Bale, et al.
Pageof 48